For years, Baltimore has been defined by negative headlines that focus on crime, decline and dysfunction. But these provocative headlines are not an accurate reflection of the full picture. The reality is that Baltimore is not overrun with criminals. It is overrun with opportunity.
As professionals who have spent our careers investing in and supporting Maryland’s innovation ecosystem, we see a very different Baltimore from the one described in those tired narratives. Every day, entrepreneurs and scientists across the Baltimore region are working together on medical breakthroughs that are changing the trajectory of health care, not just here but globally. And it’s time to rewrite the script.
Maryland’s medtech sector, in particular, is brimming with promise. Startups here are leading the way. JuneBrain is developing technology to detect neurological diseases earlier, Mi-Helper is delivering migraine relief therapy more effectively and Longeviti Neuro Solutions is making brain surgery more seamless.
These are not small, incremental changes. These companies are commercializing transformative solutions that improve and save lives while creating jobs, attracting capital and strengthening our health care infrastructure.
The numbers support the story. Maryland is consistently ranked among the top five states for life sciences, with more than 2,700 life science companies and the highest concentration of federal research funding in the nation. The Greater Baltimore-Washington corridor is anchored by institutions like Johns Hopkins, the National Institutes of Health and the University of Maryland. In 2024, venture investment into Maryland’s biohealth sector topped $2 billion.
That is why Gov. Wes Moore naturally identified life sciences as one of the state’s “lighthouse industries” for prioritization. It is a recognition that innovation in health care is not only an economic strategy but a defining part of Maryland’s future.
Baltimore is not a liability or a “hellhole” or trodden with “criminals.” It is a medical economic growth engine primed for global impact.
The same momentum extends beyond medicine. The Baltimore region is a national hub for cybersecurity, with more than 16,000 cyber engineers working in and around the city, many of them veterans of Fort Meade and the NSA. Nationally recognized cybersecurity programs at UMBC and startups at bwtech@UMBC are creating a growing ecosystem of innovation and expertise.
At the same time, housing and community revitalization projects are reshaping neighborhoods across the region. State and local initiatives are expanding affordability, modernizing infrastructure and rebuilding communities. These are the ingredients of growth and opportunity, not decline.
Still, the perception of Baltimore has not caught up with reality. The reputation of both the city and county lags far behind their progress. Every time we describe Baltimore only by its problems, we reinforce a narrative that overlooks its resilience and renewal. It is time to rewrite the story to match what is really happening on the ground, a region that is rebuilding, innovating and leading.
That does not mean ignoring our challenges. Baltimore still faces issues of public safety, housing affordability and inequality. These are real, but they are being met with urgency and creativity by leaders in business, academia and government.
We see the progress firsthand. When we back a medical device company in Baltimore, the investment does not just fund research. It creates jobs, builds labs, attracts suppliers and generates economic activity that makes the city, the county and the region stronger.
The multiplier effect is real. Baltimore’s innovation economy is rewriting its own story, one investment, one company, one success at a time.
Reducing Baltimore to a caricature only holds it back. Repeating old tropes is not analysis. It is a refusal to see how far we have come. Baltimore is producing world-class talent, world-class companies and world-changing ideas. Rewriting the narrative is not just about civic pride. It is about unlocking investment, optimism and opportunity for the next generation.
Baltimore is not accepting the status quo. It is reinventing itself in real time, and it is time the rest of the country took notice.
Maryland is on the rise, especially in terms of medical commercialization. The Baltimore region is leading that charge. If Americans — and the world — want to see what the future of innovation looks like, they should look here.
Deborah Hemingway is the founder and managing partner of Ecphora Capital, an early-stage venture capital firm in Baltimore focused on advancing medical innovation. Nick Stewart is a candidate for Baltimore County executive. He is also a partner at Duane Morris LLP, where he represents venture capital firms including Ecphora Capital, and served for eight years on Baltimore County’s Workforce Development Board.
